PHARMACIE COMPERE
ActiveSummary
PHARMACIE COMPERE has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €260,526 and a net result of -€60,619. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 89% of 22,554 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- PHARMACIE COMPERE
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Nombre, durée du mandat et, en cas de pluralité, pouvoirs, un ou plusieurs” (deed in French)“Révocation pour de justes motifs, sans indemnité quelconque” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, 186” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Saturday of June
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Délibérant dans les formes prévues pour les modifications aux statuts, en tout temps” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Peut désigner un ou plusieurs liquidateurs et déterminer pouvoirs et émoluments, pour quelque cause et à quelque moment que ce soit” (deed in French)